Headlands Research Expands with New Clinical Trial Site in El Paso, Texas

Expansion:
Headlands Research has announced the opening of a new clinical research site in El Paso, Texas, furthering its commitment to improving diversity in clinical research.

Diversity and Inclusivity:
The company emphasizes the importance of diversity and inclusivity in achieving its mission to advance innovative medical therapies for all people.

Focus Areas:
The El Paso facility will focus on multi-therapeutic and general medicine clinical trials, including metabolic & endocrine, vaccine, and healthy volunteer studies.

Partnerships:
Headlands Research has previously partnered with Pfizer to create multiple research sites aimed at increasing health equity in clinical research, and has also collaborated with Sahara Behavioral Health to improve access to clinical research in Arizona.

Global Presence:
Headlands Research is a multinational integrated clinical trial site organization with a focus on large-volume recruitment and retention of diverse, inclusive populations.